Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: An in vivo microdialysis and electrophysiological study

British Journal of Pharmacology

Volumn 127, Issue 1, 1999, Pages 145-152

  Gartside, S E ^a   Clifford, E M ^b   Cowen, P J ^b   Sharp, T ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

(+) Pindolol; ( ) Penbutolol; ( ) Tertatolol; 5 HT cell firing; Antidepressant; Extracellular 5 HT; Paroxetine; SSRI; adrenoceptor 5 HT(1A) receptor ligands

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; PENBUTOLOL; PINDOLOL; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TERTATOLOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FRONTAL CORTEX; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT;

EID: 0032936568     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702546     Document Type: Article

References (52)

1. Aghajanian, G.K., Graham, A.W. & Sheard, M.H. (1970). Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors. Science, 169, 1100-1102.
2. Aghajanian, G.K. & Vandermaelen, C.P. (1982). Intracellular identification of central noradrenergic and serotonergic neurons by a new double labeling procedure. J. Neurosci., 2, 1786-1792.
3. 1A receptors in the median raphé nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur. J. Pharmacol., 264, 259-264.
4. Artigas, F., Perez, V. & Alvarez, E. (1994). Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry, 51, 248-251.
5. 1A antagonists. Trends Neurosci., 19, 378-383.
6. Arvieu, L., Mauborgne, A., Bourgoin, S., Oliver, C., Feltz, P., Hamon, M. & Cesselin, F. (1996). Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. Neuroreport, 7, 1973-1976.
7. 1B receptors. Neuropharmacol., 35, 213-222.
8. Berman. R.M., Darnell, A.M., Miller, H.L., Anand, A. & Charney, D.S. (1997). Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double blind, placebo controlled trial. Am. J. Psychiatry. 154, 37-43.
9. Blier, P. & Bergeron, R. (1995). Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol., 15, 217-222.
10. Blier, P. & De Montigny, C. (1994). Current advances and trends in the treatment of depression. Trends Pharmacol. Sci., 15, 220-226.
11. Chaput, Y., De Montigny, C. & Blier, P. (1986). Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 333, 342-348.
12. 1A autoreceptor in vivo. Br. J. Pharmacol., 124, 206-212.
13. Delgado, P.E., Charney, D.S., Price, L.H., Aghajanian, G.K., Landis, H. & Heninger, G.R. (1990). Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry, 47, 411-418.
14. 1A receptor antagonist, WAY100635. Eur. J. Pharmacol. 281, 81-88.
15. 1A antagonists (±)-pindolol, (-)-tertatolol and (-)-penbutolol, on extracellular 5-HT in the rat cortex. Br. J. Pharmacol., 123, 232P.
16. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol., 115, 1064-1070.
17. 1A autoreceptors and noradrenergic mechanisms. Psychopharmacology, 130, 261-268.
18. 1A receptor antagonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats. J. Pharmacol. Exp. Ther., 273, 1032-1046.
19. Gundlah, C., Hjorth, S. & Auerbach, S.B. (1997). Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology, 36, 475-482.
20. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem., 60, 776-779.
21. Hjorth, S. (1996). (-)-Pindolol, but not buspirone. potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. Eur. J. Pharmacol., 303, 183-186.
22. 1A receptors orβ-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo. Eur. J. Pharmacol., 316,43-47.
23. Hjorth, S. & Carlsson, A. (1986). Is pindolol a mixed agonist, antagonist at central serotonin (5-HT) receptors? Eur. J. Pharmacol., 129, 131-138.
24. Hjorth, S. & Sharp, T. (1993). In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta-adrenoceptor antagonist (-)-penbutolol. J. Pharmacol. Exp. Ther., 265, 707-712.
25. Hughes, Z.A. & Sharp, T. (1998). Evidence that pindolol lacks the ability to enhance the effect of SSRIs on presynaptic 5-HT function. Br. J. Pharmacol., 125, 6P.
26. 1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. NeuropharmacoJogy, 36, 467-473.
27. 1A receptors in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 453-463.
28. Kosofsky, B.E. & Molliver, M.E. (1987). The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphé nuclei. Synapse, 1, 153-168.
29. 1B receptors. Eur. J. Pharmacol., 244, 77-87.
30. 1A receptors in vivo. Eur. J. Pharmacol., 240, 307-310.
31. Maione, S., Palazzo, E., Pallotta, M., Leyva, J., Berrino, L. & Rossi, F. (1997). Effects of imipramine on raphé nuclei and prefrontal cortex extracellular serotonin levels in the rat. Psychopharmacol., 134, 401-405.
32. McAskill, R., Mir, S. & Taylor, D. (1998). Pindolol augmentation of antidepressant therapy. Brit. J. Psychiatry, 173, 203-208.
33. McQuade, R. & Sharp, T. (1997). Functional mapping of dorsal and median raphé 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem., 69, 791-796.
34. Middlemiss, D.N., Blakeborough, L. & Leather, S.R. (1977). Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor. Nature, 267, 289-290.
35. 1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. J. Pharmacol. Exp. Ther., 264, 1364-1376.
36. Moreno, F.A., Gelenberg, A.J., Bachar, K. & Delgado, P.L. (1997). Pindolol augmentation of treatment-resistant depressed patients. J. Clin. Psychiatry, 58, 437-439.
37. 1A receptors. Neuropsychopharmacology, 18, 395-398.
38. Paxinos, G. & Watson, C. (1986). In: The Rat Brain in Stereotaxic Co-ordinates. Sydney: Academic Press.
39. Perez, V., Gilaberte, I., Faires, D., Alvarez, E. & Artigas, F. (1997). Randomised, double blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet, 349, 1594-1597.
40. 1A) receptor antagonist in rat brain. J. Pharmacol. Exp. Ther., 265, 739-744.
41. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacol., 15, 349-360.
42. 1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci. Lett., 219, 123-126.
43. 1A receptor ligands by means of in vivo animal models. Eur. J. Pharmacol., 315, 245-254.
44. 1B receptors and β-adrenoceptors. Eur. J. Pharmacol., 297, 1-8.
45. 1B receptor agonist with antinociceptive/ antidepressant-like actions in rodents. Br. J. Pharmacol., 105, 732-738.
46. Scuvée-Moreau, J.J. & Dresse, A.E. (1979). Effects of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. Eur. J. Pharmacol., 57, 219-225.
47. 1A receptor antagonist on 5-hydroxytryptamine cell firing and release. Eur. J. Pharmacol., 320, 15-19.
48. 1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br. J. Pharmacol., 121, 941-946.
49. Sharp, T. & ZetterströM, T. (1992). In vivo measurement of monoamine neurotransmitter release using brain microdialysis. In: Monitoring neuronal activity a practical approach, ed. Stamford J.A. pp 147-177, Oxford: IRL Press.
50. Sheard, M.H., Zolovick, A. & Aghajanian, G.K. (1972). Raphé neurons: effect of tricyclic antidepressant drugs. Brain Res., 92, 291-306.
51. Vandermaelen, C.P. & Braselton, J.P. (1992). (-)-Penbutolol antagonises 8-OH-DPAT-induced inhibition of rat 5-hydroxytryptaminergic dorsal raphe neurons. Br. J. Pharmacol., 107, 2P.
52. Zanardi, R., Artigas, F., Franchini, L., Sforzini, L., Gasperini, M., Smeraldi, E. & Perez, J. (1997). How long should pindolol be associated with paroxetine to improve the antidepressant response? J. Clin. Psychopharmacol., 17, 446 450.